Glomerulonephritis Rapidly Progressive clinical trials

Explore recruiting glomerulonephritis rapidly progressive clinical trials.

Recruiting glomerulonephritis rapidly progressive studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Glomerulonephritis Rapidly Progressive trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-Blind, Placebo-Controlled Study of Intravenously Administered ALE.F02 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Renal Sparing in Antineutrophil Cytoplasmic Antibody Associated Vasculitis With Rapidly Progressive Glomerulonephritis

Czechia, Germany, Italy, Spain, Denmark, France +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Glomerulonephritis Rapidly Progressive trials by city

Glomerulonephritis Rapidly Progressive in Toronto Glomerulonephritis Rapidly Progressive in Vancouver Glomerulonephritis Rapidly Progressive in Montreal Glomerulonephritis Rapidly Progressive in Calgary Glomerulonephritis Rapidly Progressive in Edmonton Glomerulonephritis Rapidly Progressive in Ottawa Glomerulonephritis Rapidly Progressive in Winnipeg Glomerulonephritis Rapidly Progressive in Quebec City Glomerulonephritis Rapidly Progressive in Hamilton Glomerulonephritis Rapidly Progressive in Kitchener Glomerulonephritis Rapidly Progressive in London Glomerulonephritis Rapidly Progressive in Halifax Glomerulonephritis Rapidly Progressive in New York Glomerulonephritis Rapidly Progressive in Los Angeles Glomerulonephritis Rapidly Progressive in Chicago Glomerulonephritis Rapidly Progressive in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease